August 27, 2013
August 27, 2013
August 26, 2013
A team led by UC San Francisco researchers has called for simplified guidelines on when to biopsy thyroid nodules for cancer, which they say would result in fewer unnecessary biopsies.
August 20, 2013
Septembeard.org is a clever non-profit, founded by patient Art Wagner, which raises funds for prostate cancer research by asking volunteers to grow beards during September, Prostate Cancer Awareness Month.
August 18, 2013
A natural form of sugar could offer a new, noninvasive way to precisely image tumors and potentially see whether cancer medication is effective, by means of a new imaging technology developed at UC San Francisco in collaboration with GE Healthcare.
August 16, 2013
UCSF's Resource Allocation Program (RAP), which incorporates a single online application process for a wide variety of intramural grant offerings, is now inviting applications for the Fall 2013 cycle.
August 8, 2013
UCSF’s Emmanuelle Passegué, PhD, an expert on how the blood system arises during development, recently led a study in which researchers discovered how leukemia, a blood cancer, can gain a stronghold in bone marrow and inhibit the development of normal immune cells.
August 5, 2013
Commercial casinos throughout the country are often exempt from smoke-free workplace laws. Now a new study led by UC San Francisco has found that when smoking is banned in casinos, it results in considerably fewer emergency calls for ambulances.
July 29, 2013
To address the growing problem of people being overdiagnosed and overtreated for cancer, a group of scientists convened by the National Cancer Institute and chaired by a UC San Francisco breast cancer expert is proposing a major update of the way the nation approaches diseases now classified as “cancer.”
July 19, 2013
Stem-cell researchers at UC San Francisco have found a key role for a protein called BMI1 that may help scientists direct the development of tissues to replace damaged organs in the human body.
July 18, 2013
UC San Francisco researchers have found a way to knock down cancers caused by a tumor-driving protein called "myc," paving the way for patients with myc-driven cancers to enroll in clinical trials for experimental treatments.